SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-21-025625
Filing Date
2021-10-15
Accepted
2021-10-15 19:12:32
Documents
1
Period of Report
2021-09-16

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 17031
  Complete submission text file 0001493152-21-025625.txt   18552
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Issuer) CIK: 0000890821 (see all company filings)

IRS No.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 155 RANCHRIDGE DRIVE NW CALGARY, ALBERTA Z4 T3G 1W1
Business Address
Facchini Peter J. (Reporting) CIK: 0001883966 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38286 | Film No.: 211327038